BNET Industries
Invitrogen Corp. is in the Pharma Industry
Latest News and Analysis
Invitrogen Corp. Q2 2008 Earnings Call Transcript
Question-and-Answer Session[Operator Instructions]. And the first question comes from the line of Tycho Peterson from JPMorgan. You may proceed. Tycho W. Peterson - JPMorgan Hi, good morning. Thanks for taking the call. Gregory T. Lucier - Chairman and Chief Executive Officer Good morning. David F. Hoffmeister - Chief Financial...
Invitrogen Partners With International Regulome Consortium to Advance Stem Cell Research for the Development of Life Saving Therapies
The International Regulome Consortium IRC announced today it has signed a non-binding letter of intent with Invitrogen Corporation (NASDAQ: IVGN) to develop tools for stem cell research that will aid in the development of new therapies for some of the world's most debilitating diseases. The agreement was signed here...
Invitrogen and Applied Biosystems to Combine
Strategic Combination Creates Premier Provider of Biotechnology Reagents and Systems
Invitrogen Receives FDA Clearance for Diagnostic System to Help Determine Transplant Compatibility
CARLSBAD, Calif. -- Headline of release dated June 3, 2008, should read: Invitrogen Receives FDA Clearance for Diagnostic System to Help Determine Transplant Compatibility (sted: Invitrogen Receives FDA Clearance for Diagnostic System to Determine Transplant Compatibility).
Invitrogen Wins Six Life Science Industry Awards
CARLSBAD, Calif. -- Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced it was the winner in six categories at the annual Life Science Industry Awards.
Zacks Buy List Highlights: Invitrogen Corporation, EOG Resources, Alpha Natural Resources and Oceanfreight
CHICAGO -- Zacks.com releases the latest list of Zacks Rank Buy Stocks. Every day on Zacks.com, four stock picks are made based on criteria for the each of the four main styles of investing: Aggressive Growth, Growth & Income, Momentum and Value. The four Zacks Rank Buy stocks highlighted today...
New Analyst Reports for THIRD WAVE TECHNOLOGIES INC, INTROGEN THERAPEUTICS INC, MIDDLEBROOK PHARMACEUTICALS INC, and INVITROGEN CORPORATION
Free Analyst Review
Invitrogen Launches First Ever Serum Free Media for Mesenchymal Stem Cells
Company Adds New Kits to Differentiate Mesenchymal Stem Cells
Invitrogen Advances Next Generation Sequencing Workflows
New System Streamlines Sample Preparation
Invitrogen Launches Cell Therapy Business Unit
Business to Focus on Customers' Needs in Clinical Cell Therapy Arena
Invitrogen Launches New Animal Origin Free Substrate for Stem Cells
Fully Defined, Xeno-Free Cell Culture Substrate
Invitrogen and WARF Sign License Agreement for Human Embryonic Stem Cells
CARLSBAD, Calif. & MADISON, Wis. -- Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, and the Wisconsin Alumni Research Foundation WARF, the private, non-profit patenting and licensing organization for the University of Wisconsin-Madison, announced today that they have signed a license for human...
Invitrogen Scientists Link microRNA Sequences to Cancer Using RNA Samples from BioServe
CARLSBAD, Calif. & BELTSVILLE, Md. -- In research demonstrating that RNA previously thought to have no biological relevance may be of use for therapeutic and diagnostic targets, Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, and BioServe, the leading provider of clinically annotated...
Zacks Buy List Highlights: Invitrogen Corporation, Mastercard Incorporated, Celanese Corp. and Olympic Steel
CHICAGO -- Zacks.com releases the latest list of Zacks Rank Buy Stocks. Every day on Zacks.com, four stock picks are made based on criteria for the each of the four main styles of investing: Aggressive Growth, Growth & Income, Momentum and Value. The four Zacks Rank Buy stocks highlighted today...
Invitrogen Employees Volunteer 6,000 Hours for Their Communities
CARLSBAD, Calif. -- More than 1,500 employees of Invitrogen Corporation (NASDAQ:IVGN - News), a provider of essential life science technologies for research, production and diagnostics, today donated a half day of their time to dozens of projects around the globe as part of the Company's 5th Annual Global Volunteer Day....
Invitrogen Announces Two-for-One Stock Split
CARLSBAD, Calif. -- Invitrogen Corporation (NASDAQ:IVGN) announced today that its Board of Directors has approved a two-for-one stock split of the company's common stock. The Board established May 16, 2008, as the record date and May 27, 2008, as the date on which additional shares will be distributed to shareholders.
Invitrogen to Present at Upcoming Investor Conferences
CARLSBAD, Calif. -- Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, announced today the company will present at the following upcoming investor conferences:
Invitrogen Corp. Q1 2008 Earnings Call Transcript
Question-and-Answer Session[Operator Instructions]. Your first question comes from the line Jon Wood from Banc of America Securities. Please proceed, sir. Jon D. Wood - Banc of America Securities Thanks a lot. David you talked about it qualitatively. Can you possibly cheese out what price added in the quarter? David...
Invitrogen Announces First Quarter 2008 Results
First quarter revenue of $350 million, 13.5 percent increase
Invitrogen Teams with MitoSciences to Improve Mitochondrial Disease Research
Invitrogen to become exclusive North American Distributor
- Next »
- page 1 of 16
- « Previous
Sort byClose
View by Content TypeClose
View Related Content by Tag Close
- agreement (15 results)
- stock (14 results)
- health care (14 results)
- life science (10 results)
- (10 results)
- Cell (9 results)
- Webcast (9 results)
- stem-cell (9 results)
- Molecular Inc. (8 results)
- biotechnology (7 results)
- collaboration (6 results)
- pro-forma earnings (6 results)
- board (5 results)
- protein (4 results)
- Company (4 results)
- RNA (4 results)
- Lehman Brothers Inc. (4 results)
- leader (4 results)
- UBS AG (4 results)
- J.P. Morgan Chase & Co. (4 results)
- DNA (4 results)
- acquisition (4 results)
- board of directors (3 results)
- Bank of America Corp. (3 results)
- team (3 results)
- licensing agreement (3 results)
- Nasdaq Stock Market Inc. (3 results)
Invitrogen Corp. Company Info
NAICS Code
Biological Product (except Diagnostic) Manufacturing: 325414
